Showing results (1661-1670 of 1,701) with videos related to

Sort By:
Pageof 171
The Journal of Molecular Diagnostics : JMD|February 21, 2025
Repurposing the Whole Expression Transcriptome Assay for the Genetic Diagnosis of T-Cell Acute Lymphoblastic Leukemia and LymphomaValentina Bardelli, Silvia Arniani, Valentina Pierini, et al.
Plos One|August 25, 2020
Triple-negative breast cancer in Peru: 2000 patients and 15 years of experienceGabriel De-la-Cruz-Ku, Marianne Luyo, Zaida Morante, et al.
Plos Neglected Tropical Diseases|June 5, 2026
Severe visceral leishmaniasis in Ethiopia: Outcomes, co-infections and mortality in a prospective real-world cohortEleni Ayele, Saskia van Henten, Desalew Getahun Ayalew, et al.
Nature Communications|August 22, 2023
Histone H3 serine-57 is a CHK1 substrate whose phosphorylation affects DNA repairNikolaos Parisis, Pablo D Dans, Muhammad Jbara, et al.
Plos One|June 23, 2021
COVID-19 pneumonia in Galicia (Spain): Impact of prognostic factors and therapies on mortality and need for mechanical ventilationLuis Pérez-de-Llano, Eva María Romay-Lema, Adolfo Baloira-Villar, et al.
Journal of Clinical Medicine|November 13, 2025
Optimization of the Use of Generic Medications in Oncology: Improving Safety and Therapeutic QualityDiego Gómez Abreo, Daniel F Alarcón Cano, Fernando Ayala, et al.
European Journal of Cancer (Oxford, England : 1990)|January 8, 2025
Efficacy outcomes of CDK4/6 inhibitors in combination with endocrine therapy treatment in hormone receptor-positive/HER2-negative advanced breast cancer according to PAM50 intrinsic subtype: Primary results of SOLTI-1801 CDK-PREDICT studyPablo Tolosa, Tomás Pascual, Olga Martínez-Saez, et al.
Genome Research|July 7, 2005
Mutation scanning by meltMADGE: validations using BRCA1 and LDLR, and demonstration of the potential to identify severe, moderate, silent, rare, and paucimorphic mutations in the general populationKhalid K Alharbi, Mohammed A Aldahmesh, Emmanuel Spanakis, et al.
Human Genomics|June 18, 2024
Germline mutations of breast cancer susceptibility genes through expanded genetic analysis in unselected Colombian patientsDiana Carolina Sierra-Díaz, Adrien Morel, Dora Janeth Fonseca-Mendoza, et al.
American Heart Journal|December 28, 2025
Dual versus monotherapy with SGLT2 inhibitor and GLP-1 receptor agonist:PRECIDENTD pragmatic randomized trialDeborah J Wexler, Lindsay S Mayberry, Lyndsay A Nelson, et al.
Pageof 171